CAJ | 학술논문

慢性心力衰竭（CHF）是各种心血管疾病的终末阶段，发病率逐年增高，亟待提高诊治水平。近年来，CHF 的诊断、分期有了新的观点；以血管紧张素转化酶抑制剂（ACEI）、β受体阻滞剂和醛固酮受体拮抗剂为基础的多药物联合应用，大大降低了 CFH 的死亡率和再住院率；在此基础上进行的心脏同步化治疗、植入型心律转复除颤器、机械循环支持等非药物治疗，进一步改善了患者的预后；干细胞移植等为 CHF 治疗提供了新的希望。本文对 CHF 的诊断、药物治疗及非药物治疗最新的发展及国内外最新指南进行综述。
만성심력쇠갈（CHF）시각충심혈관질병적종말계단，발병솔축년증고，극대제고진치수평。근년래，CHF 적진단、분기유료신적관점；이혈관긴장소전화매억제제（ACEI）、β수체조체제화철고동수체길항제위기출적다약물연합응용，대대강저료 CFH 적사망솔화재주원솔；재차기출상진행적심장동보화치료、식입형심률전복제전기、궤계순배지지등비약물치료，진일보개선료환자적예후；간세포이식등위 CHF 치료제공료신적희망。본문대 CHF 적진단、약물치료급비약물치료최신적발전급국내외최신지남진행종술。
Chronic heart failure (CHF) is the terminal stage of various cardiovascular diseases, the incidence increased year by year, the level of diagnosis and treatment should be improved. In recent years, there is a new point of view on the diagnosis and staging of CHF. The combination of ACEI, beta blockers, and aldosterone receptor antagonist on the basis of many drugs, greatly reduces the CFH mortality and hospitalization rates again. On the basis of cardiac synchronization therapy, implantable cardioverter-defibrillator, mechanical circulation support and other non-drug therapy, further improve the prognosis of patients with CHF. Stem cell transplantation provides new hope for CHF treatment. In this paper, the diagnosis of CHF, drug therapy and non-drug therapy at home and abroad, the latest developments and the latest guidelines were reviewed.